HARRISBURG – Attorney General Dave Sunday announced that Pennsylvania has joined a multistate coalition in securing $17.85 million in settlements with generic drug manufacturers Lannett Company, Inc. and Bausch Health over allegations the companies conspired to inflate prices and restrict competition.
The settlements resolve claims that the companies participated in long-running schemes to manipulate prices of certain generic prescription drugs sold nationwide, including Pennsylvania, between May 2009 and December 2019. As part of the agreements, both companies will cooperate with ongoing litigation against additional pharmaceutical manufacturers and executives, and implement internal reforms to comply with antitrust laws.
“Pennsylvania consumers rely on generic medications to keep health care affordable,” Attorney General Sunday said. “When companies illegally raise prices and eliminate competition, families, seniors, and patients on fixed incomes pay the price. This settlement helps return money to Pennsylvanians who were overcharged and sends a clear message that drug companies will be held accountable for putting profits over people.”
The Lannett and Bausch settlements follow earlier multistate agreements, totaling $49.1 million. Pennsylvania continues to participate in ongoing antitrust litigation against numerous pharmaceutical manufacturers, with the first trial anticipated in late 2026.
Also today, a coalition of 42 states and territories, including Pennsylvania, will file a new lawsuit against pharmaceutical companies Novartis and its generic subsidiary Sandoz. The complaint alleges the companies engaged in a coordinated scheme to fix prices, allocate markets, and rig bids for dozens of generic prescription drugs sold nationwide.
Pennsylvanians who purchased generic prescription drugs manufactured by Lannett or Bausch between May 1, 2009, and December 31, 2019, may be eligible for compensation.
To learn more or check eligibility, call 1-866-290-0182, email in**@************gs.com, or visit www.AGGeneric Drugs.com.
The following states and territories that joined Pennsylvania in today’s settlements with Lannett and Bausch include Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, and Puerto Rico.
States and territories filing the new lawsuit against Novartis and Sandoz include Alaska, Arizona, California, Connecticut, Colorado, Delaware, District of Columbia, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Dakota, Tennessee, Vermont, U.S. Virgin Islands, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.
